The hype around the hair loss industry
There is an insane amount of hype in many health
product industries, whether it be weight loss aids, acne removal and
of course hair loss. All the time, we encounter clickbait headlines
like "Oranges hold the cure to hair loss" in the media.
Most of these articles are based around conclusions that the
journalists have drawn from latest scientific research. There are
several problems with this.
-
The latest research is not always correct.
-
New research means treading into new territory. Scientists make educated guesses, which the research is consistent with. It doesn't mean the guess is always correct.
-
Some science is badly done.
-
-
Many journalists are not scientists
-
When the read scientific literature, they don't always accurately assess the credibility of the article.
-
Journalists very often blow things out of proportion in order to attract readers.
-
In this article, I plan to point out three things
you can look out for when reading a scientific study about hair loss.
Things to look for in hair loss articles
in vitro and in vivo
In vitro and in vivo are two
commonly used scientific terms, and it is one of the crucial factors
in determining how reliable the results of an experiment is. In
vitro are so called "test tube experiments". It is
where cells and molecules are studied outside of their natural
context. The main weakness of in vitro experiments is that
they don't precisely replicate the cellular conditions of the
organism. Consequently, results of in vitro studies may not
apply to the living organism.
For example, consider the published scientific
paper “Procyanidin B-2, extracted from apples, promotes hairgrowth: a laboratory study.” This paper was published in 2002 in
the British Journal of Dermatology. In this paper, it was shown that
adding certain inhibitors that stop an enzyme called protein kinase
A to the a mouse hair epithelial cell culture change the activity of
some of its genes. The gene changes were associates with hair growth.
The main limitation of this study is that it was
that these compounds were directly added to cells in culture. The
compounds may not work the same way when applied directly to a human
scalp or when taken orally. As a result, the result of this study by
itself is not enough to show that procyanidin B2 can treat hair loss.
In vivo (a latin phrase for “within the
living”) refers to experiments done using a complete, living
organism. Animal studies and clinical trials are two forms of in
vivo research. In vivo experiments is often preferred
to in vitro as the overall effects/results of an experiment
tends to be more applicable to the living subject.
Consider the scientific study “Investigation oftopical application of procyanidin B-2 from apple to identify itspotential use as a hair growing agent.”, published in the Journal
Phytomedicine in the year 2000. In this experiment, procyanidin B2
was applied to the heads of 19 men. A corresponding placebo group had
10 men. After treatment, the men treated with procyanidin B2 had
increased hair growth and hair diameter.
This is an example of an in vivo study. It should
be easy to see that it provides much stronger evidence that
procyanidin B2 can be used to treat hair loss. In particular, the
study demonstrates the the compound can work in humans.
Even after animal trials suggest that a drug or compound will be safe and effective in humans, greater than 80% of potential therapeutics fail in clinical trials. Part of the problem lies in that any symptoms and conditions that scientists treat in mice is simply just a model for a human disease. Thus, not all treatments translate across from animals to humans.
Animal studies vs human trials
The next major guideline I would suggest is to consider whether the study uses animals or human. Returning to our previous example - "Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study". This study uses hair epithelial cells from mice. Results obtained using hair epithelial cells from humans would be more compelling.Even after animal trials suggest that a drug or compound will be safe and effective in humans, greater than 80% of potential therapeutics fail in clinical trials. Part of the problem lies in that any symptoms and conditions that scientists treat in mice is simply just a model for a human disease. Thus, not all treatments translate across from animals to humans.
No comments:
Post a Comment